Why Lenz Therapeutics Stock Plummeted by Almost 20% This Week [Yahoo! Finance]
LENZ Therapeutics, Inc. (LENZ)
Company Research
Source: Yahoo! Finance
by just under 20% over the course of this trading week. Investors were in a bearish mood following a disappointing earnings report from the specialty healthcare company . This was exacerbated by aggressive price target cuts from two prominent banks. Two significant misses On Tuesday morning, Lenz published its fourth-quarter and full-year 2025 results. These revealed that the company earned revenue of just under $1.59 million for the former period. As its first commercial product, VIZZ, won Food and Drug Administration (FDA) approval last October, that figure compared exceedingly well to the fourth quarter 2024 result of $0. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Image source: Getty Images. Commercialization entails costs, however, which is a key reason Lenz's net loss under generally accepted acc
Show less
Read more
Impact Snapshot
Event Time:
LENZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LENZ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LENZ alerts
High impacting LENZ Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
LENZ
News
- LENZ Therapeutics: Q4 Results Highlight A Worrying Lack Of Market Demand (Rating Downgrade) [Seeking Alpha]Seeking Alpha
- LENZ Therapeutics (LENZ) had its price target lowered by Citigroup Inc. from $52.00 to $26.00. They now have a "buy" rating on the stock.MarketBeat
- LENZ Therapeutics (LENZ) had its price target lowered by Bank of America Corporation from $35.00 to $29.00. They now have a "buy" rating on the stock.MarketBeat
- LENZ Therapeutics, Inc. (LENZ) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- LENZ Therapeutics Inc (LENZ) Q4 2025 Earnings Call Highlights: Strong Cash Position and ... [Yahoo! Finance]Yahoo! Finance
LENZ
Earnings
- 3/24/26 - Miss
LENZ
Sec Filings
- 3/24/26 - Form S-8
- 3/24/26 - Form 10-K
- 3/24/26 - Form 8-K
- LENZ's page on the SEC website